OALib Journal期刊
ISSN: 2333-9721
费用：99美元

投递稿件

查看量	下载量

相关文章
更多...

PLOS ONE 2013

Cancer-Associated Fibroblasts Promote Proliferation of Endometrial Cancer Cells

DOI: 10.1371/journal.pone.0068923

Kavita S. Subramaniam, Seng Tian Tham, Zahurin Mohamed, Yin Ling Woo, Noor Azmi Mat Adenan, Ivy Chung

Full-Text Cite this paper Add to My Lib

Abstract:

Endometrial cancer is the most commonly diagnosed gynecologic malignancy worldwide; yet the tumor microenvironment, especially the fibroblast cells surrounding the cancer cells, is poorly understood. We established four primary cultures of fibroblasts from human endometrial cancer tissues (cancer-associated fibroblasts, CAFs) using antibody-conjugated magnetic bead isolation. These relatively homogenous fibroblast cultures expressed fibroblast markers (CD90, vimentin and alpha-smooth muscle actin) and hormonal (estrogen and progesterone) receptors. Conditioned media collected from CAFs induced a dose-dependent proliferation of both primary cultures and cell lines of endometrial cancer in vitro (175%) when compared to non-treated cells, in contrast to those from normal endometrial fibroblast cell line (51%) (P<0.0001). These effects were not observed in fibroblast culture derived from benign endometrial hyperplasia tissues, indicating the specificity of CAFs in affecting endometrial cancer cell proliferation. To determine the mechanism underlying the differential fibroblast effects, we compared the activation of PI3K/Akt and MAPK/Erk pathways in endometrial cancer cells following treatment with normal fibroblasts- and CAFs-conditioned media. Western blot analysis showed that the expression of both phosphorylated forms of Akt and Erk were significantly down-regulated in normal fibroblasts-treated cells, but were up-regulated/maintained in CAFs-treated cells. Treatment with specific inhibitors LY294002 and U0126 reversed the CAFs-mediated cell proliferation (P<0.0001), suggesting for a role of these pathways in modulating endometrial cancer cell proliferation. Rapamycin, which targets a downstream molecule in PI3K pathway (mTOR), also suppressed CAFs-induced cell proliferation by inducing apoptosis. Cytokine profiling analysis revealed that CAFs secrete higher levels of macrophage chemoattractant protein (MCP)-1, interleukin (IL)-6, IL-8, RANTES and vascular endothelial growth factor (VEGF) than normal fibroblasts. Our data suggests that in contrast to normal fibroblasts, CAFs may exhibit a pro-tumorigenic effect in the progression of endometrial cancer, and PI3K/Akt and MAPK/Erk signaling may represent critical regulators in how endometrial cancer cells respond to their microenvironment.

References

[1]	Jemal A, Bray F, Center MM, Ferlay J, Ward E et al. (2011) Global cancer statistics. CA Cancer J Clin 61: 69-90. doi:10.3322/caac.20107. PubMed: 21296855.
[2]	Society AC (2012) Cancer Facts & Figures 2012. American Cancer Society.
[3]	Bakkum-Gamez JN, Gonzalez-Bosquet J, Laack NN, Mariani A, Dowdy SC (2008) Current issues in the management of endometrial cancer. Mayo Clin Proc 83: 97-112. doi:10.4065/83.1.97. PubMed: 18174012.
[4]	Amant F, Moerman P, Neven P, Timmerman D, Van Limbergen E et al. (2005) Endometrial cancer. Lancet 366: 491-505. doi:10.1016/S0140-6736(05)67063-8. PubMed: 16084259.
[5]	Bokhman JV (1983) Two pathogenetic types of endometrial carcinoma. Gynecol Oncol 15: 10-17. doi:10.1016/0090-8258(83)90111-7. PubMed: 6822361.
[6]	Brachtel EF, Sánchez-Estevez C, Moreno-Bueno G, Prat J, Palacios J et al. (2005) Distinct molecular alterations in complex endometrial hyperplasia (CEH) with and without immature squamous metaplasia (squamous morules). Am J Surg Pathol 29: 1322-1329. doi:10.1097/01.pas.0000171001.87599.e2. PubMed: 16160475.
[7]	Mutter GL, Zaino RJ, Baak JP, Bentley RC, Robboy SJ (2007) Benign endometrial hyperplasia sequence and endometrial intraepithelial neoplasia. Int J Gynecol Pathol 26: 103-114. doi:10.1097/PGP.0b013e31802e4696. PubMed: 17413975.
[8]	Kaaks R, Lukanova A, Kurzer MS (2002) Obesity, Endogenous Hormones, and Endometrial Cancer Risk. Cancer Epidemiol Biomarkers Prev 11: 1531-1543. PubMed: 12496040.
[9]	Trimble CL, Kauderer J, Zaino R, Silverberg S, Lim PC et al. (2006) Concurrent endometrial carcinoma in women with a biopsy diagnosis of atypical endometrial hyperplasia: a Gynecologic Oncology Group study. Cancer 106: 812-819. doi:10.1002/cncr.21650. PubMed: 16400639.
[10]	Plataniotis G, Castiglione M (2010) Endometrial cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Ann Oncol 21: 41-45. doi:10.1093/annonc/mdq245. PubMed: 20555100.
[11]	Cunha GR, Hayward SW, Wang YZ, Ricke WA (2003) Role of the stromal microenvironment in carcinogenesis of the prostate. Int J Cancer 107: 1-10. doi:10.1002/ijc.11335. PubMed: 12925950.
[12]	Hwang RF, Moore T, Arumugam T, Ramachandran V, Amos KD et al. (2008) Cancer-associated stromal fibroblasts promote pancreatic tumor progression. Cancer Res 68: 918-926. doi:10.1158/0008-5472.CAN-07-5714. PubMed: 18245495.
[13]	Cunha GR, Bigsby RM, Cooke PS, Sugimura Y (1985) Stromal-epithelial interactions in adult organs. Cell Differ 17: 137-148. doi:10.1016/0045-6039(85)90481-6. PubMed: 3902250.
[14]	Cooke PS, Uchima FD, Fujii DK, Bern HA, Cunha GR (1986) Restoration of normal morphology and estrogen responsiveness in cultured vaginal and uterine epithelia transplanted with stroma. Proc Natl Acad Sci U S A 83: 2109-2113. doi:10.1073/pnas.83.7.2109. PubMed: 3457377.
[15]	Tlsty TD, Coussens LM (2006) Tumor stroma and regulation of cancer development. Annu Rev Pathol 1: 119-150. doi:10.1146/annurev.pathol.1.110304.100224. PubMed: 18039110.
[16]	Franco OE, Hayward SW (2012) Targeting the tumor stroma as a novel therapeutic approach for prostate cancer. Adv Pharmacol 65: 267-313. doi:10.1016/B978-0-12-397927-8.00009-9. PubMed: 22959029.
[17]	Cunha GR, Young P (1992) Role of stroma in oestrogen-induced epithelial proliferation. Epithelial Cell Biol 1: 18-31. PubMed: 1307934.
[18]	Chung LW, Li W, Gleave ME, Hsieh JT, Wu HC et al. (1992) Human prostate cancer model: roles of growth factors and extracellular matrices. J Cell Biochem Suppl 16H: 99-105. PubMed: 1289680.
[19]	Johansson AC, Ansell A, Jerhammar F, Lindh MB, Grénman R et al. (2012) Cancer-associated fibroblasts induce matrix metalloproteinase-mediated cetuximab resistance in head and neck squamous cell carcinoma cells. Mol Cancer Res 10: 1158-1168. doi:10.1158/1541-7786.MCR-12-0030. PubMed: 22809838.
[20]	Kojima Y, Acar A, Eaton EN, Mellody KT, Scheel C et al. (2010) Autocrine TGF-beta and stromal cell-derived factor-1 (SDF-1) signaling drives the evolution of tumor-promoting mammary stromal myofibroblasts. Proc Natl Acad Sci U S A 107: 20009-20014. doi:10.1073/pnas.1013805107. PubMed: 21041659.
[21]	O’Connell JT, Sugimoto H, Cooke VG, MacDonald BA, Mehta AI et al. (2011) VEGF-A and Tenascin-C produced by S100A4+ stromal cells are important for metastatic colonization. Proc Natl Acad Sci U S A 108: 16002-16007. doi:10.1073/pnas.1109493108. PubMed: 21911392.
[22]	Vong S, Kalluri R (2012) The role of stromal myofibroblast and extracellular matrix in tumor angiogenesis. Genes Cancer 2: 1139-1145.
[23]	Raz Y, Erez N (2013) An inflammatory vicious cycle: Fibroblasts and immune cell recruitment in cancer. Exp Cell Res. PubMed: 23567181.
[24]	Wagatsuma S, Konno R, Sato S, Yajima A (1998) Tumor angiogenesis, hepatocyte growth factor, and c-Met expression in endometrial carcinoma. Cancer 82: 520-530. doi:10.1002/(SICI)1097-0142(19980201)82:3. PubMed: 9452270.
[25]	Gelmini S, Mangoni M, Castiglione F, Beltrami C, Pieralli A et al. (2009) The CXCR4/CXCL12 axis in endometrial cancer. Clin Exp Metastasis 26: 261-268. doi:10.1007/s10585-009-9240-4. PubMed: 19199057.
[26]	Arnold JT, Lessey BA, Sepp？l？ M, Kaufman DG (2002) Effect of normal endometrial stroma on growth and differentiation in Ishikawa endometrial adenocarcinoma cells. Cancer Res 62: 79-88. PubMed: 11782363.
[27]	Shi M, Zhang H, Li M, Xue J, Fu Y et al. (2011) Normal endometrial stromal cells regulate survival and apoptosis signaling through PI3K/AKt/Survivin pathway in endometrial adenocarcinoma cells in vitro. Gynecol Oncol 123: 387-392. doi:10.1016/j.ygyno.2011.07.004. PubMed: 21794903.
[28]	Arnold JT, Kaufman DG, Sepp？l？ M, Lessey BA (2001) Endometrial stromal cells regulate epithelial cell growth in vitro: a new co-culture model. Hum Reprod 16: 836-845. doi:10.1093/humrep/16.5.836. PubMed: 11331626.
[29]	Schlemmer SR, Kaufman DG (2000) Endometrial Stromal Cells Regulate Gap-Junction Function in Normal Human Endometrial Epithelial Cells but not in Endometrial Carcinoma Cells. Mol Carcinog 28: 70-75. doi:10.1002/1098-2744(200006)28:2. PubMed: 10900463.
[30]	Samalecos A, Reimann K, Wittmann S, Schulte HM, Brosens JJ et al. (2009) Characterization of a novel telomerase-immortalized human endometrial stromal cell line, St-T1b. Reprod Biol Endocrinol 7: 76. doi:10.1186/1477-7827-7-76. PubMed: 19619280.
[31]	Jones EA, English A, Kinsey SE, Straszynski L, Emery P et al. (2006) Optimization of a Flow Cytometry-Based Protocol for Detection and Phenotypic Characterization of Multipotent Mesenchymal Stromal Cells from Human Bone Marrow. Cytometry B (Clinical Cytometry) 70B: 391-399. doi:10.1002/cyto.b.20118.
[32]	Jones EA, Kinsey SE, English A, Jones RA, Straszynski L et al. (2002) Isolation and Characterization of Bone Marrow Multipotential Mesenchymal Progenitor Cells. Arthritis Rheum 46: 3349-3360. doi:10.1002/art.10696. PubMed: 12483742.
[33]	Krüger W, Datta C, Badbaran A, T？gel F, Gutensohn K et al. (2000) Immunomagnetic tumor cell selection--implications for the detection of disseminated cancer cells. Transfusion 40: 1489-1493. doi:10.1046/j.1537-2995.2000.40121489.x. PubMed: 11134569.
[34]	Krüger W, T？gel F, R？ssing S, Kr？ger N, Zander AR (1999) Improvement of breast cancer cell detection by immunomagnetic enrichment. Cytotherapy 1: 135-139. doi:10.1080/0032472031000141251. PubMed: 19746590.
[35]	Classen-Linke I, Alfer J, Krusche CA, Chwalisz K, Rath W et al. (2000) Progestins, progesterone receptor modulators, and progesterone antagonists change VEGF release of endometrial cells in culture. Steroids 65: 763-771. doi:10.1016/S0039-128X(00)00180-X. PubMed: 11108887.
[36]	Tanaka R, Saito T, Ashihara K, Nishimura M, Mizumoto H et al. (2003) Three-dimensional coculture of endometrial cancer cells and fibroblasts in human placenta derived collagen sponges and expression matrix metalloproteinases in these cells. Gynecol Oncol 90: 297-304. doi:10.1016/S0090-8258(03)00335-4. PubMed: 12893190.
[37]	Arentz G, Chataway T, Price TJ, Izwan Z, Hardi G et al. (2011) Desmin expression in colorectal cancer stroma correlates with advanced stage disease and marks angiogenic microvessels. Clin Proteomics 8: 1-13. doi:10.2174/157016411794697390. PubMed: 22141345.
[38]	Gangadhara S, Barrett-Lee P, Nicholson RI, Hiscox S (2012) Pro-metastatic Tumor-stroma Interactions in Breast Cancer. Future Oncol 11: 1427-1442. PubMed: 23148616.
[39]	Ban S, Shimizu M (2009) Muscularis mucosae in desmoplastic stroma formation of early invasive rectal adenocarcinoma. World J Gastroenterol 15: 4976–4979. doi:10.3748/wjg.15.4976. PubMed: 19842233.
[40]	Hammond MG, Oh ST, Anners J, Surrey ES, Halme J (1993) The effect of growth factors on the proliferation of human endometrial stromal cells in culture. Am J Obstet Gynecol 168: 1131-1136; discussion 1136-1138. doi:10.1016/0002-9378(93)90356-N. . PubMed : 8475958.
[41]	Matrisian LM, Gaire M, Rodgers WH, Osteen KG (1994) Metalloproteinase expression and hormonal regulation during tissue remodeling in the cycling human endometrium. Contrib Nephrol 107: 94-100. PubMed: 8004979.
[42]	Osteen KG, Rodgers WH, Gaire M, Hargrove JT, Gorstein F et al. (1994) Stromal-epithelial interaction mediates steroidal regulation of metalloproteinase expression in human endometrium. Proc Natl Acad Sci U S A 91: 10129-10133. doi:10.1073/pnas.91.21.10129. PubMed: 7937850.
[43]	Modugno F, Ness RB, Chen C, Weiss NS (2005) Inflammation and endometrial cancer: a hypothesis. Cancer Epidemiol Biomarkers Prev 14: 2840-2847. doi:10.1158/1055-9965.EPI-05-0493. PubMed: 16364998.
[44]	Chung I, Karpf AR, Muindi JR, Conroy JM, Nowak NJ et al. (2007) Epigenetic silencing of CYP24 in tumor-derived endothelial cells contributes to selective growth inhibition by calcitriol. J Biol Chem 282: 8704-8714. doi:10.1074/jbc.M608894200. PubMed: 17244627.
[45]	Dudley AC (2012) Tumor endothelial cells. Cold Spring Harb Perspect Med: a006536. p. 2.
[46]	Zagouri F, Bozas G, Kafantari E, Tsiatas M, Nikitas N et al. (2010) Endometrial cancer: what is new in adjuvant and molecularly targeted therapy? Obstet Gynecol Int, 2010: 2010: 749579. PubMed: 20148071.
[47]	Bae-Jump VL, Zhou C, Boggess JF, Gehrig PA (2009) Synergistic effect of rapamycin and cisplatin in endometrial cancer cells. Cancer 115: 3887-3896. doi:10.1002/cncr.24431. PubMed: 19484784.
[48]	Slomovitz BM, Lu KH, Johnston T, Coleman RL, Munsell M et al. (2010) A phase 2 study of the oral mammalian target of rapamycin inhibitor, everolimus, in patients with recurrent endometrial carcinoma. Cancer 116: 5415-5419. doi:10.1002/cncr.25515. PubMed: 20681032.
[49]	Shafer A, Zhou C, Gehrig PA, Boggess JF, Bae-Jump VL (2010) Rapamycin potentiates the effects of paclitaxel in endometrial cancer cells through inhibition of cell proliferation and induction of apoptosis. Int J Cancer 126: 1144-1154. PubMed: 19688827.
[50]	Zhou X, Tan M, Stone Hawthorne V, Klos KS, Lan KH et al. (2004) Activation of the Akt/mammalian target of rapamycin/4E-BP1 pathway by ErbB2 overexpression predicts tumor progression in breast cancers. Clin Cancer Res 10: 6779-6788. doi:10.1158/1078-0432.CCR-04-0112. PubMed: 15501954.
[51]	Squillace RM, Miller D, Cookson M, Wardwell SD, Moran L et al. (2011) Antitumor activity of ridaforolimus and potential cell-cycle determinants of sensitivity in sarcoma and endometrial cancer models. Mol Cancer Ther 10: 1959-1968. doi:10.1158/1535-7163.MCT-11-0273. PubMed: 21825008.
[52]	Gadducci A, Tana R, Cosio S, Fanucchi A, Genazzani AR (2008) Molecular target therapies in endometrial cancer: from the basic research to the clinic. Gynecol Endocrinol 24: 239-249. doi:10.1080/09513590801953556. PubMed: 18569027.
[53]	Aksamitiene E, Kiyatkin A, Kholodenko BN (2012) Cross-talk between mitogenic Ras/MAPK and survival PI3K/Akt pathways: a fine balance. Biochem Soc Trans 40: 139-146. doi:10.1042/BST20110609. PubMed: 22260680.
[54]	Gentilini D, Busacca M, Di Francesco S, Vignali M, Viganò P et al. (2007) PI3K/Akt and ERK1/2 signalling pathways are involved in endometrial cell migration induced by 17b-estradiol and growth factors. Mol Hum Reprod 13: 317-322. doi:10.1093/molehr/gam001. PubMed: 17350964.
[55]	Fujimoto H, Sangai T, Ishii G, Ikehara A, Nagashima T et al. (2009) Stromal MCP-1 in mammary tumors induces tumor-associated macrophage infiltration and contributes to tumor progression. Int J Cancer 125: 1276-1284. doi:10.1002/ijc.24378. PubMed: 19479998.
[56]	Yoshimura T, Howard OM, Ito T, Kuwabara M, Matsukawa A et al. (2013) Monocyte Chemoattractant Protein-1/CCL2 Produced by Stromal Cells Promotes Lung Metastasis of 4T1 Murine Breast Cancer Cells. PLOS ONE 8: e58791. doi:10.1371/journal.pone.0058791. PubMed: 23527025.
[57]	Dagouassat M, Suffee N, Hlawaty H, Haddad O, Charni F et al. (2010) Monocyte chemoattractant protein-1 (MCP-1)/CCL2 secreted by hepatic myofibroblasts promotes migration and invasion of human hepatoma cells. Int J Cancer 126: 1095-1108. PubMed: 19642141.
[58]	Su X, Ye J, Hsueh EC, Zhang Y, Hoft DF et al. (2010) Tumor microenvironments direct the recruitment and expansion of human Th17 cells. J Immunol 184: 1630-1641. doi:10.4049/jimmunol.0902813. PubMed: 20026736.
[59]	Wang SW, Wu HH, Liu SC, Wang PC, Ou WC et al. (2010) CCL5 and CCR5 interaction promotes cell motility in human osteosarcoma. PLOS ONE 7: e35101. PubMed: 22506069.
[60]	Huang CY, Fong YC, Lee CY, Chen MY, Tsai HC et al. (2009) CCL5 increases lung cancer migration via PI3K, Akt and NF-kappaB pathways. Biochem Pharmacol 77: 794-803. doi:10.1016/j.bcp.2008.11.014. PubMed: 19073147.
[61]	Yokoyama Y, Charnock-Jones DS, Licence D, Yanaihara A, Hastings JM et al. (2003) Expression of vascular endothelial growth factor (VEGF)-D and its receptor, VEGF receptor 3, as a prognostic factor in endometrial carcinoma. Clin Cancer Res 9: 1361-1369. PubMed: 12684405.
[62]	Kamat AA, Merritt WM, Coffey D, Lin YG, Patel PR et al. (2007) Clinical and biological significance of vascular endothelial growth factor in endometrial cancer. Clin Cancer Res 13: 7487-7495. doi:10.1158/1078-0432.CCR-07-1017. PubMed: 18094433.
[63]	Coso S, Zeng Y, Opeskin K, Williams ED (2012) Vascular endothelial growth factor receptor-3 directly interacts with phosphatidylinositol 3-kinase to regulate lymphangiogenesis. PLOS ONE 7: e39558. doi:10.1371/journal.pone.0039558. PubMed: 22745786.
[64]	Pinto MP, Badtke MM, Dudevoir ML, Harrell JC, Jacobsen BM et al. (2010) Vascular endothelial growth factor secreted by activated stroma enhances angiogenesis and hormone-independent growth of estrogen receptor-positive breast cancer. Cancer Res 70: 2655-2664. doi:10.1158/1538-7445.AM10-2655. PubMed: 20332242.
[65]	Becker C, Fantini MC, Wirtz S, Nikolaev A, Lehr HA et al. (2005) IL-6 signaling promotes tumor growth in colorectal cancer. Cell Cycle 4: 217-220. PubMed: 15655344.
[66]	Tu Y, Gardner A, Lichtenstein A (2000) The phosphatidylinositol 3-kinase/AKT kinase pathway in multiple myeloma plasma cells: roles in cytokine-dependent survival and proliferative responses. Cancer Res 60: 6763-6770. PubMed: 11118064.
[67]	Lee YS, Choi I, Ning Y, Kim NY, Khatchadourian V et al. (2010) Interleukin-8 and its receptor CXCR2 in the tumour microenvironment promote colon cancer growth, progression and metastasis. Br J Cancer 106: 1833-1841. PubMed: 22617157.
[68]	Yuan A, Chen JJ, Yao PL, Yang PC (2005) The role of interleukin-8 in cancer cells and microenvironment interaction. Front Biosci 10: 853-865. doi:10.2741/1579. PubMed: 15569594.
[69]	Yamaji H, Iizasa T, Koh E, Suzuki M, Otsuji M et al. (2004) Correlation between interleukin 6 production and tumor proliferation in non-small cell lung cancer. Cancer Immunol Immunother 53: 786-792. PubMed: 15185009.
[70]	Lai Y, Liu XH, Zeng Y, Zhang Y, Shen Y et al. (2012) Interleukin-8 induces the endothelial cell migration through the Rac 1/RhoA-p38MAPK pathway. Eur Rev Med Pharmacol Sci 16: 630-638. PubMed: 22774404.
[71]	Luppi F, Longo AM, de Boer WI, Rabe KF, Hiemstra PS (2007) Interleukin-8 stimulates cell proliferation in non-small cell lung cancer through epidermal growth factor receptor transactivation. Lung Cancer 56: 25-33. doi:10.1016/j.lungcan.2006.11.014. PubMed: 17175059.
[72]	Kinoshita H, Hirata Y, Nakagawa H, Sakamoto K, Hayakawa Y et al. (2013) Interleukin-6 mediates epithelial-stromal interactions and promotes gastric tumorigenesis. PLOS ONE 8: e60914. doi:10.1371/journal.pone.0060914. PubMed: 23593346.
[73]	Tu B, Du L, Fan QM, Tang Z, Tang TT (2012) STAT3 activation by IL-6 from mesenchymal stem cells promotes the proliferation and metastasis of osteosarcoma. Cancer Lett 325: 80-88. doi:10.1016/j.canlet.2012.06.006. PubMed: 22743617.
[74]	Abell K, Watson CJ (2005) The Jak/Stat pathway: a novel way to regulate PI3K activity. Cell Cycle 4: 897-900. doi:10.4161/cc.4.7.1837. PubMed: 15970662.
[75]	Bournazou EB, [!(surname)!] (2013) Targeting the tumor microenvironment: JAK-STAT3 signaling 2. Landes Bioscience. p. e23828.
[76]	Burger JA, Stewart DJ, Wald O, Peled A (2011) Potential of CXCR4 antagonists for the treatment of metastatic lung cancer. Expert Rev Anticancer Ther 11: 621-630. doi:10.1586/era.11.11. PubMed: 21504328.
[77]	Orimo A, Gupta PB, Sgroi DC, Arenzana-Seisdedos F, Delaunay T et al. (2005) Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 121: 335-348. doi:10.1016/j.cell.2005.02.034. PubMed: 15882617.
[78]	Donjacour AA, Cunha GR (1991) Stromal regulation of epithelial function. Cancer Treat Res 53: 335-364. doi:10.1007/978-1-4615-3940-7_16. PubMed: 1672086.
[79]	Lu TY, Lu RM, Liao MY, Yu J, Chung CH et al. (2010) Epithelial cell adhesion molecule regulation is associated with the maintenance of the undifferentiated phenotype of human embryonic stem cells. J Biol Chem 285: 8719-8732. doi:10.1074/jbc.M109.077081. PubMed: 20064925.
[80]	Burke JM, Cao F, Irving PE, Skumatz CM (1999) Expression of E-cadherin by human retinal pigment epithelium: delayed expression in vitro. Invest Ophthalmol Vis Sci 40: 2963-2970. PubMed: 10549658.
[81]	Traweek ST, Liu J, Battifora H (1993) Keratin gene expression in non-epithelial tissues. Detection with polymerase chain reaction. Am J Pathol 142: 1111-1118. PubMed: 7682761.
[82]	Szeto CC, Chan RW, Lai KB, Szeto CY, Chow KM et al. (2005) Messenger RNA expression of target genes in the urinary sediment of patients with chronic kidney diseases. Nephrol Dial Transplant 20: 105-113. doi:10.1093/ndt/gfh574. PubMed: 15561743.
[83]	Luo Y, He DL, Ning L, Shen SL, Li L et al. (2006) Hypoxia-inducible factor-1alpha induces the epithelial-mesenchymal transition of human prostatecancer cells. Chin Med J (Engl) 119: 713-718. PubMed: 16701010.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133